Eupry provides a portfolio of solutions to monitor and perform validation of temperature, CO2, humidity and differential pressure for regulated and temperature-sensitive industries. The company targets regulated storage and distribution for sectors including laboratory, pharmacy, healthcare, pharma and food. Eupry says its mission is to secure access to high-quality medication and sensitive products by demystifying regulation and simplifying compliant storage processes. Founded in 2012, the company uses innovative technology to support validation and monitoring workflows. In August 2022 Eupry raised €2.4M in funding to strengthen its offerings and accelerate international expansion. The Danish Growth Fund Vækstfonden will take a board seat as part of the investment.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Aug 2022